Author

N. C. Riola

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:non-human primate· 1 Organism:virus· 1

Frequent Co-Authors

V. Du Pont· 2 shared A. Ambrosi· 1 shared A. Davie· 1 shared A. Niedziela-Majka· 1 shared A.-Q. Nguyen· 1 shared B. Bleier· 1 shared B. M. O'Keefe· 1 shared C. Hedskog· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

V. Du Pont

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pharmacology & ToxicologybioRxivApr 28, 2023

Discovery of GS-5245 (Obeldesivir), an Oral Prodrug of Nucleoside GS-441524 that Exhibits Antiviral Efficacy in SARS-CoV-2 Infected African Green Monkeys

R. L. Mackman, R. Kalla, D. Babusis…·T. Cihlar

DOI 10.1021/acs.jmedchem.3c00750

non-human primateexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivFeb 7, 2022

In Vitro Selection of Remdesivir-Resistant SARS-CoV-2 Demonstrates High Barrier to Resistance.

L. Checkmahomed, V. Du Pont, N. C. Riola…·G. Boivin

This study shows that remdesivir resistance in SARS-CoV-2 develops slowly, with a single mutation conferring limited resistance.

DOI 10.1128/aac.00198-22

virusexperimental assay

𝕏 PostBluesky